Oculocutaneous albinism.
Grønskov K, Ek J, Brondum-Nielsen K.
Orphanet J Rare Dis. 2007 Nov 2;2:43. doi: 10.1186/1750-1172-2-43.
Oculocutaneous Albinism Type 4.
Hayashi M, Suzuki T.
2005 Nov 17 [updated 2017 Sep 7]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
[Oculocutaneous and ocular albinism].
Kubasch AS, Meurer M.
Hautarzt. 2017 Nov;68(11):867-875. doi: 10.1007/s00105-017-4061-x.
Albinism.
Federico JR, Krishnamurthy K.
2023 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Oculocutaneous Albinism Type 1 - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY.
Lewis RA.
2000 Jan 19 [updated 2013 May 16]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Oculocutaneous albinism type 1: the last 100 years.
Oetting WS, Fryer JP, Shriram S, King RA.
Pigment Cell Res. 2003 Jun;16(3):307-11. doi: 10.1034/j.1600-0749.2003.00045.x.
Oculocutaneous Albinism Type 2 - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY.
Lewis RA.
2003 Jul 17 [updated 2012 Aug 16]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Compound heterozygosity in type-II oculocutaneous albinism.
Doshi S, Sawarthia S, Hegde SS, Sardesai VR.
Indian J Dermatol Venereol Leprol. 2025 Mar 28:1-3. doi: 10.25259/IJDVL_1121_2024. Online ahead of print.
Oculocutaneous albinism in southern Africa: Historical background, genetic, clinical and psychosocial issues.
Kromberg JGR, Kerr R.
Afr J Disabil. 2022 Oct 14;11:877. doi: 10.4102/ajod.v11i0.877. eCollection 2022.
Tyrp1 and oculocutaneous albinism type 3.
Sarangarajan R, Boissy RE.
Pigment Cell Res. 2001 Dec;14(6):437-44. doi: 10.1034/j.1600-0749.2001.140603.x.
